References

Akbarian S, Halene T. The neuroepigenetics of suicide. Am J Psychiatry. 2013;170:462–465.

Aleman A, Denys D. Mental health: A road map for suicide research and prevention. Nature. 2014;509:421–423.

Arcelus J, Mitchell A, Wales J, et al. Mortality rates in patients with anorexia nervosa and other eating disorders. Arch Gen Psychiatry. 2011;68:724–731.

Benros ME, Waltoft BL, Nordentoft M, et al. Autoimmune diseases and severe infections as risk factors for mood disorders: A nationwide study. JAMA Psychiatry. 2013;70:812–820.

Black D, Miller BJ. Meta-analysis of cytokines and chemokines in suicidality: distinguishing suicidal versus nonsuicidal patients. Biol Psychiatry. 2015;78:28–37.

Bridge JA, Iyengar S, Salary CB, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA. 2007;297:1683–1696.

Advertisement

Brundon L, Erhardt S, Bryleva EY, et al. The role of inflammation in suicidal behavior. Acta Psychiatr Scand. 2015;132:193–203.

Chesney E, Goodwin GM, Fazel S. Risks of all-cause and suicide mortality in mental disorders: a meta-review. World Psychiatry. 2014;13:153–160.

Curtin S, Reidenberg D, Stone D, et al. Increase in suicide in the United States, 1999–2014 [online article]. May 22, 16. http://www.cdc.gov/nchs/products/databriefs/db241.htm.

Dodd D, Smith A, Bodell L. Restraint feeds stress: the relationship between eating disorder symptoms, stress generation, and the interpersonal theory of suicide. Eat Behav. 2014;15, 567–573.

Gabbay V, Klein RG, Guttman LE, et al. A preliminary study of cytokines in suicidal and nonsuicidal adolescents with major depression. J Child Adolesc Psychopharmacol. 2009;19:423–430.

Ganança L, Oquendio MA, Tyrka AR, et al. The role of cytokines in the pathophysiology of suicidal behavior. Psychoneuroloendocrinology. 2016 Jan;63:296–310.

Guintivano J, Brown T, Newcomer, A, et al. Identification and replication of a combined epigenetic and genetic biomarker predicting suicide and suicidal behaviors. Am J Psychiatry. 2014 Dec 1;171(12)1287–1296. doi:10.1176/appi.a-jp.2014.14010008.

Kin YK, Lee SW, Shim SH, et al. Differences in cytokines between non-suicidal patients and suicidal patients in major depression. 2008. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:356–361.

LaBonte B, Suderman M, Maussion G, et al. Genome-side methylation changes in the brains of suicide completers. Am J Psychiatry. 2013;170:511–520.

Nischal A, Tripalti A, et al. Suicide and antidepressants: what current evidence indicates. Mens Sana Mongr. 2012;10:22–44.

Noury JL, Nardo JM, Healy D, et al. Restoring study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence. Br Med J. 2015;351:1–16.

Pandey GN. Cytokines as suicide risk biomarkers. Biol Psychiatry. 2015;78:15–16.

Perlis RH, Huang J, Purcell S, et al. Genome-wide association study of suicide attempts in mood disorder patients. Am J Psychiatry. 2010;167:1499–1507.

Preti A, Rocchi M, Sisti D, et al. A comprehensive meta-analysis of the risk of suicide in eating disorders. Acta Psychiatr Scand. 2011;124:6–17.

Rihmer Z. Suicide risk in mood disorders. Curr Opin Psychiatry. 2007;20:17–22.

Rudolf S, Greggersen W, Kahl KG, et al. Elevated IL-6 levels in patients with atypical depression but not in patients with typical depression. Psychiatry Res. 2014;217:34–38.

Selby E, Smith A, Bulik C, et al. Habitual starvation and provocative behaviors: two potential routes to extreme suicidal behavior in anorexia nervosa. Behav Res Ther. 2010;48:634–645.

Smith A, Fink E, Anestis M, et al. Exercise caution: over-exercise is associated with suicidality among individuals with disordered eating. Psychiatry Res. 2013;206:246–255.

Suokas J, Suvisaari J, Grainger M, et al. Suicide attempts and mortality in eating disorders: a follow-up study of eating disorder patients. 2014. Gen Hosp Psychiatry. http://dx.doi.org/10.1016/j.genhosppsych.2014.01.002.

Teicher MH, Glod C, Cole JO. Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry.1990;147:207–210.

World Health Organization. Preventing Suicide: A Global Imperative. Geneva: WHO; 2014.

Wu S, Ding Y, Wu F, et al. Serum lipid levels and suicidality: a meta-analysis of 65 epidemiological studies. J Psychiatry Neurosci. 2016;41:56–68.

Yen S, Shea MT, Sanislaw CA, et al. Personality traits as prospective predictors of suicide attempts. Acta Psychiatr Scand. 2009;9:120–122.

Yin H, Pantazatos SP, Galfalvy H, et al. A pilot integrative genomics study of GABA and glutamate neurotransmitter systems in suicide, suicidal behavior, and major depressive disorder. Am J Med Genet. 2016;171B:414–426.

Zalsman G Hawton K, Wasserman D, et al. Suicide prevention strategies revisited: ten-year systematic review. Lancet Psychiatry. Epub June 8, 2016.

Authors

Already Subscribed?

Search

Formatting updates are ongoing for older articles.

Author

Featured Articles

Where are your Clinical Trials?

It has proven to be difficult, if not impossible, to proceed to full-scale randomized controlled trials (RCTs) for most of the natural methods that cannot be patented or otherwise monopolized. 

A Renewed Focus on Self-Help for Healing

As the producer of The Moss Report, the year leading up to the Covid-19 pandemic was filled with anticipation and excitement. We had invested years of hard work and significant resources into two major projects: our feature film, Immunotherapy: The Battle Within, and...

Issue Archives

Event Calendar

  • Integrative Cancer Symposium 2026 – Believe BIG

    Sheraton, Towson MD Towson, MD, United States

    Optimize Your Health. Transform Your Future. Join us for this dynamic one-day experience designed for anyone seeking to take a proactive, whole-body approach to health. Integrative oncology is a dynamic and rapidly evolving field, unveiling groundbreaking discoveries and new possibilities every day. This year’s one-day conference will take place at the Sheraton in Towson, Maryland from 9am – 5pm and offers both in-person and virtual attendance options. This event brings together leading experts in integrative oncology, functional medicine, and wellness. Discover cutting-edge approaches to prevention, treatment, recovery, and whole-person wellness at the Integrative Cancer Symposium Believe Big 2026. Learn from leading clinicians, researchers, and innovators in integrative oncology as they explore emerging therapies, metabolic and lifestyle approaches, mistletoe therapy, nutrition, environmental health, mindset, and more. Whether you are navigating cancer personally, supporting a loved one, or simply looking to optimize your health and reduce future risk, this powerful one-day experience offers practical tools, fresh insights, and meaningful connection.

  • PLMI 14th Annual Thought Leaders Consortium

    Loews Coronado Bay Resort 4000 Coronado Bay Rd, Coronado, CA, United States

    The 14th Annual Thought Leaders Consortium marks the culminating chapter of PLMI’s three-year exploration into the biology of immuno-metabolism, epigenetic regulation, and human longevity. Building on the 2024 and 2025 Consortia—which reframed chronic disease through immune-metabolic dysfunction and diet- and environment-driven epigenetic remodeling—this year’s gathering places mitochondria at the center of health, disease, and aging. Once viewed simply as the cell’s energy producers, mitochondria are now recognized as dynamic, epigenetically responsive organelles that integrate nutrition, environmental exposures, immune activation, stress signaling, physical activity, and circadian inputs into a unified metabolic-immune system. Disruption of mitochondrial function is increasingly implicated in fatigue syndromes, chronic pain, immune dysregulation, neurodegeneration, infertility, metabolic disease, accelerated aging, and diminished stress resilience. This advanced, science-driven Consortium convenes world-leading experts to explore mitochondrial biology as the cornerstone of immuno-metabolic resilience. Attendees will gain cutting-edge insights into mitochondrial signaling, mito-nuclear communication, and metabolic flexibility—alongside clinically actionable frameworks for restoring cellular vitality, reversing biological aging trajectories, and extending healthspan. Through deep scientific exploration and translational clinical strategy, the 2026 Thought Leaders Consortium will equip practitioners and researchers with the knowledge needed to redefine assessment, intervention, and long-term outcomes in personalized and lifestyle medicine.

    $650
  • Practical Clinical Skills in Neurotransmitter Optimization: Clinical Herbalism for Mood, Cognition & Aging

    Virtual Event

    Join us for the second part of this two-part virtual symposium! Mental health and neurocognitive disorders remain among the most prevalent and inadequately addressed challenges in modern clinical practice.  This intensive, expert-led symposium provides a comprehensive, clinically grounded framework for integrating herbal and nutraceutical strategies into mental health care. Attendees gain a working understanding of how targeted herbal interventions modulate key neurotransmitter systems, including serotonin, dopamine, GABA, and cortisol, and how to apply these therapies strategically, whether as adjuncts to pharmaceuticals or as standalone options. Clinical applications span a wide spectrum, from anxiety and depression to Parkinson’s-related motor symptoms and age-associated cognitive decline, with a strong emphasis on practical implementation and patient-specific protocol design.

Related Posts

The GMO-to-Cancer Pathway

By Michelle Perro, MD – Early-onset colorectal cancer, generally defined as colorectal cancer diagnosed before age 50, has been rising for decades. The phenomenon is particularly disturbing because many cases occur in people without an obvious hereditary cancer syndrome.

Read More

0 Comments

Submit a Comment

Pin It on Pinterest

Share This